Therapeutic applications of organosulfur compounds as novel hydrogen sulfide donors and/or mediators.
about
Differential mechanisms underlying neuroprotection of hydrogen sulfide donors against oxidative stress.Therapeutic uses and pharmacological properties of garlic, shallot, and their biologically active compounds.The summer of hydrogen sulfide: highlights from two international conferences.Emerging role of hydrogen sulfide in health and disease: critical appraisal of biomarkers and pharmacological tools.Garlic and cardioprotection: insights into the molecular mechanisms.An outlook on vascular hydrogen sulphide effects, signalling, and therapeutic potential.Chemical foundations of hydrogen sulfide biology.Chinese Medicine: A Hope for Neurodegenerative Diseases?Diallyl trisulfide ameliorates myocardial ischemia-reperfusion injury by reducing oxidative stress and endoplasmic reticulum stress-mediated apoptosis in type 1 diabetic rats: role of SIRT1 activation.Toward Hydrogen Sulfide Based Therapeutics: Critical Drug Delivery and Developability Issues.Alliin, a garlic (Allium sativum) compound, prevents LPS-induced inflammation in 3T3-L1 adipocytes.Inhibition of hydrogen sulfide synthesis provides protection for severe acute pancreatitis rats via apoptosis pathway.Cruciferous and Allium Vegetable Intakes are Inversely Associated With 15-Year Atherosclerotic Vascular Disease Deaths in Older Adult Women.Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke.Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia.
P2860
Q33692977-91CBCE93-B9CC-4ED0-8FE5-7B9CC57FD51CQ34395014-692CE3AD-0272-4632-AA4A-1453CC3999A5Q36688790-661AF271-5B5D-4FB2-8DAC-542B5FC7DB37Q37917815-5CD9FEC4-35A9-4D4E-9DF7-748AB8DC15E5Q38112809-87257E06-A507-4A55-9818-A96ACA814C22Q38117636-863A802F-DC07-4ABD-ACD8-D85E8132798FQ38121347-0DEDDE31-51F9-4F52-A309-F81BD087B023Q38663621-6265E022-35C1-4158-B7E4-BFD7E5C5FE9AQ38813231-B9FF0750-EFEA-4F20-BF1B-F5546049774EQ39152370-DB88D6EE-1411-4C83-BF93-EDB2745750A4Q41814637-ED51646B-1714-4504-BC36-734ECA9E8BFDQ43685420-D41439D4-2788-4716-9943-F7894705EA97Q47129397-431E6973-6D56-48CD-A605-BB098C8CFF8BQ50203349-365F7B96-97C0-4FDF-9393-08C9C712A14FQ50224206-6D706DA0-465A-4828-BF08-D32CDCC39C00
P2860
Therapeutic applications of organosulfur compounds as novel hydrogen sulfide donors and/or mediators.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Therapeutic applications of or ...... lfide donors and/or mediators.
@en
Therapeutic applications of or ...... lfide donors and/or mediators.
@nl
type
label
Therapeutic applications of or ...... lfide donors and/or mediators.
@en
Therapeutic applications of or ...... lfide donors and/or mediators.
@nl
prefLabel
Therapeutic applications of or ...... lfide donors and/or mediators.
@en
Therapeutic applications of or ...... lfide donors and/or mediators.
@nl
P2860
P356
P1476
Therapeutic applications of or ...... lfide donors and/or mediators.
@en
P2093
Xianfeng Gu
Yi Zhun Zhu
P2860
P304
P356
10.1586/ECP.10.129
P407
P577
2011-01-01T00:00:00Z